Search for Clinical Trial Results

Sponsored By

Primary Biliary Cholangitis - 13 Studies Found

Status Study
Completed Study Name: MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension)
Condition: Primary Biliary Cirrhosis
Date: 2016-11-02
Interventions:
  • Drug: MBX-8025 5 mg Capsule Op
Completed Study Name: A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients
Condition: Primary Biliary Cholangitis
Date: 2015-08-04
Interventions:
  • Drug: LJN452 LJN452 capsules a
Active, not recruiting Study Name: Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis
Condition: Primary Biliary Cirrhosis
Date: 2015-12-19
Not yet recruiting Study Name: A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)
Condition: Primary Biliary Cirrhosis
Date: 2017-04-10
Interventions:
  • Drug: Saroglitazar magnesium 2 mg

Completed Study Name: Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Date: 2008-12-08
Interventions:
  • Drug: Tetrathiomolybdate 120 m
Completed Study Name: Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Date: 2015-09-21
Interventions: Dietary Supplement: S-adenosyl-L-methionine Patients will be treated with S-adenosyl-L-methionine, table
Completed Study Name: High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Date: 2012-05-17
Interventions: Dietary Supplement: High protein high fiber diet A personalized high protein high fiber dietary plan wil
NOT_YET_RECRUITING Study Name: CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
Condition:
Date: 2025-05-16
Interventions: Oral QD
Completed Study Name: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Condition: Primary Biliary Cholangitis
Date: 2025-05-16
Interventions: Seladelpar 10 mg one capsule daily for up to 36 months.
Completed Study Name: A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Condition: Primary Biliary Cholangitis (PBC)
Date: 2025-05-16
Interventions: Duration: up to an estimated 84-month (7-year) double-blind treatment period during which elafibranor 80 mg tablet will be administered once daily
Next >>>